These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8960830)

  • 21. Evaluation of a structured outpatient group education program for intensive insulin therapy.
    Pieber TR; Brunner GA; Schnedl WJ; Schattenberg S; Kaufmann P; Krejs GJ
    Diabetes Care; 1995 May; 18(5):625-30. PubMed ID: 8585999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern of long-term complications in Sudanese insulin-treated diabetic patients.
    Elbagir MN; Eltom MA; Mahadi EO; Berne C
    Diabetes Res Clin Pract; 1995 Oct; 30(1):59-67. PubMed ID: 8745207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes.
    Warnock GL; Thompson DM; Meloche RM; Shapiro RJ; Ao Z; Keown P; Johnson JD; Verchere CB; Partovi N; Begg IS; Fung M; Kozak SE; Tong SO; Alghofaili KM; Harris C
    Transplantation; 2008 Dec; 86(12):1762-6. PubMed ID: 19104418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study.
    Reichard P; Pihl M
    Diabetes; 1994 Feb; 43(2):313-7. PubMed ID: 8288056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
    Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
    J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.
    Nordwall M; Hyllienmark L; Ludvigsson J
    J Pediatr Endocrinol Metab; 2006 Jan; 19(1):45-54. PubMed ID: 16509528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes; 1997 Nov; 46(11):1829-39. PubMed ID: 9356033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoglycaemic episodes during intensified insulin treatment: increased frequency but no effect on cognitive function.
    Reichard P; Berglund A; Britz A; Levander S; Rosenqvist U
    J Intern Med; 1991 Jan; 229(1):9-16. PubMed ID: 1995769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of microvascular complications in type 1 diabetic patients 10 years follow-up.
    Kulenovic I; Rasic S; Karcic S
    Bosn J Basic Med Sci; 2006 May; 6(2):47-50. PubMed ID: 16879113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycated hemoglobin variability and microvascular complications in patients with type 1 diabetes mellitus.
    Er E; Ata A; Evin F; Altınok YA; Demir G; Özen S; Darcan Ş; Gökşen D
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1533-1537. PubMed ID: 33581707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Martin CL; Albers JW; Pop-Busui R;
    Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia.
    ter Braak EW; Appelman AM; van de Laak M; Stolk RP; van Haeften TW; Erkelens DW
    Diabetes Care; 2000 Oct; 23(10):1467-71. PubMed ID: 11023138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
    Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy.
    Reichard P; Rosenqvist U
    J Intern Med; 1989 Aug; 226(2):81-7. PubMed ID: 2671247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy.
    Mühlhauser I; Overmann H; Bender R; Jörgens V; Berger M
    Diabet Med; 2000 Oct; 17(10):727-34. PubMed ID: 11110506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database.
    Kilpatrick ES; Rigby AS; Atkin SL; Frier BM
    Diabet Med; 2012 Sep; 29(9):1195-8. PubMed ID: 22332940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.